Sheree Smith
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sheree Smith has a total of 141 co-authors. Here are the top co-authors by number of shared publications:
- Belinda Cochrane
Department of Respiratory and Sleep Medicine, Campbelltown Hospital, Campbelltown, NSW, Australia
3 shared publications - Jonathan Shung-Yi Lee
Department of Respiratory and Sleep Medicine, Campbelltown Hospital, Campbelltown, NSW, Australia
3 shared publications - Luisa Garcia
School of Nursing and Midwifery, Western Sydney University
3 shared publications - Soo Foo
Department of Respiratory and Sleep Medicine, Campbelltown Hospital, Campbelltown, NSW, Australia
3 shared publications - Teresa Kemp
Department of Respiratory and Sleep Medicine, Campbelltown Hospital, Campbelltown, NSW, Australia
3 shared publications - Tracy A Smith
Department of Respiratory and Sleep Medicine, Westmead Hospital, Westmead, NSW, Australia
3 shared publications
Latest Publications
- Open Access
- 1 June 2026
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 21, 1-15
Breathlessness Matters – Australian Cohort Study Evaluating the Impact of a Multidisciplinary, Home-Based Breathlessness Intervention Service Targeting Patients with Chronic Obstructive Pulmonary Disease (COPD)
Background and Objectives: Chronic breathlessness causes reduced quality of life (QoL) and high healthcare costs. Accumulating evidence shows that multidisciplinary breathlessness services can ameliorate breathlessness which persists despite guideline-directed treatments. Current literature largely reflects trials of interventions in European settings applied to cancer-predominant populations, raising doubt about broad applicability. The research objective was to evaluate whether Macarthur Breathless Clinic (MBC), a bespoke health service intervention, could reduce the impact of chronic breathlessness for a cohort of Australians with COPD. Methods: The MBC intervention was tested in a prospective, single-arm cohort study, targeting recruitment of 92 patients. Eligible patients had chronic breathlessness impacting QoL and at least moderately severe COPD, defined by spirometry. Following detailed case review to ensure optimal medical therapy, an individualized program was developed and implemented by MBC’s multidisciplinary team during a nine-week program. Questionnaires assessing breathlessness burden, mental health and QoL were administered at baseline, repeated on program completion and again at 12 months. Results: Eighty-nine eligible subjects were mean age 71 years, 65% female and 10% Aboriginal Australian with 18% reporting breathlessness at rest. Mean FEV1 was 37% predicted. Compared with baseline, the primary outcome, Chronic Respiratory Questionnaire – Mastery Subscale improved after program completion (0.5 at nine and 0.8 at 52 weeks, p< 0.0001). Measures of confidence, COPD symptom burden and breathlessness also yielded durable positive results at 12 months. Conclusion: Clinically relevant gains seen after MBC were retained or even increased at 12 months and more reflected enhanced coping skills and confidence than reduced breathlessness intensity. Plain Language Summary: Breathlessness is a distressing, disabling symptom, contributing to high healthcare costs. Hence, addressing breathlessness represents an unmet need for patients and a health system priority. Breathlessness intervention services, largely comprising non-pharmacological strategies have proven beneficial for patients in the short term; largely for those patients with life-limiting disease such as cancer. Chronic obstructive pulmonary disease (COPD) and emphysema are common conditions, increasing in prevalence worldwide. Even with best available treatments, such patients have persistent and pervasive symptom burden, particularly from breathlessness. This research explores the utility of a breathlessness intervention service for durable impact when applied to patients with COPD. We report sustained improvements in breathlessness mastery and related symptom burden at 12 months following a multidisciplinary, home-based breathlessness intervention program in a cohort of Australians with COPD.
- 1 June 2026
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 21, 1-15
Open AccessBreathlessness Matters – Australian Cohort Study Evaluating the Impact of a Multidisciplinary, Home-Based Breathlessness Intervention Service Targeting Patients with Chronic Obstructive Pulmonary Disease (COPD)
Background and Objectives: Chronic breathlessness causes reduced quality of life (QoL) and high healthcare costs. Accumulating evidence shows that multidisciplinary breathlessness services can ameliorate breathlessness which persists despite guideline-directed treatments. Current literature largely reflects trials of interventions in European settings applied to cancer-predominant populations, raising doubt about broad applicability. The research objective was to evaluate whether Macarthur Breathless Clinic (MBC), a bespoke health service intervention, could reduce the impact of chronic breathlessness for a cohort of Australians with COPD. Methods: The MBC intervention was tested in a prospective, single-arm cohort study, targeting recruitment of 92 patients. Eligible patients had chronic breathlessness impacting QoL and at least moderately severe COPD, defined by spirometry. Following detailed case review to ensure optimal medical therapy, an individualized program was developed and implemented by MBC’s multidisciplinary team during a nine-week program. Questionnaires assessing breathlessness burden, mental health and QoL were administered at baseline, repeated on program completion and again at 12 months. Results: Eighty-nine eligible subjects were mean age 71 years, 65% female and 10% Aboriginal Australian with 18% reporting breathlessness at rest. Mean FEV1 was 37% predicted. Compared with baseline, the primary outcome, Chronic Respiratory Questionnaire – Mastery Subscale improved after program completion (0.5 at nine and 0.8 at 52 weeks, p< 0.0001). Measures of confidence, COPD symptom burden and breathlessness also yielded durable positive results at 12 months. Conclusion: Clinically relevant gains seen after MBC were retained or even increased at 12 months and more reflected enhanced coping skills and confidence than reduced breathlessness intensity. Plain Language Summary: Breathlessness is a distressing, disabling symptom, contributing to high healthcare costs. Hence, addressing breathlessness represents an unmet need for patients and a health system priority. Breathlessness intervention services, largely comprising non-pharmacological strategies have proven beneficial for patients in the short term; largely for those patients with life-limiting disease such as cancer. Chronic obstructive pulmonary disease (COPD) and emphysema are common conditions, increasing in prevalence worldwide. Even with best available treatments, such patients have persistent and pervasive symptom burden, particularly from breathlessness. This research explores the utility of a breathlessness intervention service for durable impact when applied to patients with COPD. We report sustained improvements in breathlessness mastery and related symptom burden at 12 months following a multidisciplinary, home-based breathlessness intervention program in a cohort of Australians with COPD.
- Open Access
- 2 April 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e85766
A Personalized, Home-Based, Multidisciplinary Outpatient Clinic for Managing Breathlessness in Chronic Obstructive Pulmonary Disease: Protocol for a Single-Arm, Mixed-Methods Cohort Study
Background: Breathlessness is a distressing symptom for people with chronic obstructive pulmonary disease (COPD), impacting independence and community participation, resulting in reduced quality of life. With optimized treatment, nonpharmaceutical interventions deployed in a home-based breathlessness intervention service may reduce breathlessness to a manageable level. Objective: The aim of this study is to investigate whether patients with COPD experience reduced burden of chronic breathlessness and health care use following participation in the Macarthur Breathless Clinic (MBC), a multidisciplinary home-based health service intervention and to explore participant and carer experiences. Methods: The proposed research is a single-site, mixed methods, single-arm cohort study evaluating MBC. Eligible participants will have chronic breathlessness as defined by a modified Medical Research Council score of at least 2 and COPD confirmed by spirometry. Initially, participants will undergo a holistic medical assessment to understand factors contributing to breathlessness and to optimize therapy. The MBC intervention will be a 9-week, home-based, multidisciplinary program (with contributions from medical, nursing, physiotherapy, and occupational therapy clinicians). Central to this program will be coaching for breathlessness self-management using individualized, multicomponent strategies. Breathlessness impact will be assessed using questionnaire instruments measuring breathlessness mastery, symptom burden, quality of life, and psychological distress, with the Chronic Respiratory Questionnaire’s mastery subscale as primary outcome. Assessments will be undertaken at baseline, 9 weeks, and 52 weeks; 12-month exacerbation rates, health care use, and rescue medication use will be monitored and measured against participants’ historical data. Participant and carer experiences will be evaluated using qualitative methods to inform development of the service. Results: This project was funded in stages according to defined milestones, with the final milestone payment received in October 2025. Data collection commenced in March 2022. On submission of this manuscript, recruitment is complete with 92 participants having completed the protocol by March 2024. Data analysis is ongoing, and results are expected to be reported by early 2027. Conclusions: This research protocol is the first to investigate long-term outcomes following a health service intervention targeting chronic breathlessness for patients with COPD. Positive results may see breathlessness strategies from MBC or other similar health service interventions incorporated into existing models of chronic COPD care. Trial Registration: Australian and New Zealand Clinical Trial Registry ACTRN12620001330932; https://tinyurl.com/35fec8h4 International Registered Report Identifier (IRRID): DERR1-10.2196/85766
- 2 April 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e85766
Open AccessA Personalized, Home-Based, Multidisciplinary Outpatient Clinic for Managing Breathlessness in Chronic Obstructive Pulmonary Disease: Protocol for a Single-Arm, Mixed-Methods Cohort Study
Background: Breathlessness is a distressing symptom for people with chronic obstructive pulmonary disease (COPD), impacting independence and community participation, resulting in reduced quality of life. With optimized treatment, nonpharmaceutical interventions deployed in a home-based breathlessness intervention service may reduce breathlessness to a manageable level. Objective: The aim of this study is to investigate whether patients with COPD experience reduced burden of chronic breathlessness and health care use following participation in the Macarthur Breathless Clinic (MBC), a multidisciplinary home-based health service intervention and to explore participant and carer experiences. Methods: The proposed research is a single-site, mixed methods, single-arm cohort study evaluating MBC. Eligible participants will have chronic breathlessness as defined by a modified Medical Research Council score of at least 2 and COPD confirmed by spirometry. Initially, participants will undergo a holistic medical assessment to understand factors contributing to breathlessness and to optimize therapy. The MBC intervention will be a 9-week, home-based, multidisciplinary program (with contributions from medical, nursing, physiotherapy, and occupational therapy clinicians). Central to this program will be coaching for breathlessness self-management using individualized, multicomponent strategies. Breathlessness impact will be assessed using questionnaire instruments measuring breathlessness mastery, symptom burden, quality of life, and psychological distress, with the Chronic Respiratory Questionnaire’s mastery subscale as primary outcome. Assessments will be undertaken at baseline, 9 weeks, and 52 weeks; 12-month exacerbation rates, health care use, and rescue medication use will be monitored and measured against participants’ historical data. Participant and carer experiences will be evaluated using qualitative methods to inform development of the service. Results: This project was funded in stages according to defined milestones, with the final milestone payment received in October 2025. Data collection commenced in March 2022. On submission of this manuscript, recruitment is complete with 92 participants having completed the protocol by March 2024. Data analysis is ongoing, and results are expected to be reported by early 2027. Conclusions: This research protocol is the first to investigate long-term outcomes following a health service intervention targeting chronic breathlessness for patients with COPD. Positive results may see breathlessness strategies from MBC or other similar health service interventions incorporated into existing models of chronic COPD care. Trial Registration: Australian and New Zealand Clinical Trial Registry ACTRN12620001330932; https://tinyurl.com/35fec8h4 International Registered Report Identifier (IRRID): DERR1-10.2196/85766
- Open Access
- 24 October 2025
- Published by Wiley in The Clinical Respiratory Journal
- Vol. 19 (10) , e70132
Comparison of Single Versus Multiple Nonpharmacological Interventions for the Management of Lung Cancer–Related Fatigue: A Systematic Review
Background: Lung cancer is one of the common cancers globally. One of the adverse symptoms of lung cancer and its treatment is fatigue. Pharmacological interventions have not shown efficacy on cancer‐related fatigue, and investigations on nonpharmacological interventions may be useful. This systematic review aims to evaluate the efficacy of nonpharmacological interventions on managing fatigue and quality of life outcomes among people undergoing treatment for lung cancer and evaluate if treatment efficacy differed between single and multimodal interventions. Methods: Relevant literature published in MEDLINE, Scopus, Cochrane Library, CINAHL, and ProQuest from January 2003 to January 2023 was included. Included studies must have: participants over 16 years of age receiving treatment such as chemotherapy, radiotherapy, and/or surgery, cancer‐related fatigue (CRF) as an outcome, and must be randomized controlled trials. Two reviewers independently extracted data from eligible articles, and data analysis was performed using R 4.1.0 software. Results: Total of 14 randomized controlled trials were included and categorized into four groups: physical activities, traditional Chinese medicine (TCM), education, and dietary counselling. Our extensive search did not find any multimodal studies related to CRF in patients with lung cancer. Pooled results of this systematic review found that TCM and education interventions have a significant positive impact on fatigue in patients with lung cancer. Physical activity and dietary counselling were not effective in managing fatigue. None of the reported nonpharmacological interventions in this review significantly impact QoL. Conclusions: This review identified that TCM and educational programs improved CRF in patients with lung cancer. However, physical activities and dietary counselling did not show any improvements in fatigue for patients undergoing lung cancer treatment. Registration: PROSPERO registration ID: CRD42023407326.
- 24 October 2025
- Published by Wiley in The Clinical Respiratory Journal
- Vol. 19 (10) , e70132
Open AccessComparison of Single Versus Multiple Nonpharmacological Interventions for the Management of Lung Cancer–Related Fatigue: A Systematic Review
Background: Lung cancer is one of the common cancers globally. One of the adverse symptoms of lung cancer and its treatment is fatigue. Pharmacological interventions have not shown efficacy on cancer‐related fatigue, and investigations on nonpharmacological interventions may be useful. This systematic review aims to evaluate the efficacy of nonpharmacological interventions on managing fatigue and quality of life outcomes among people undergoing treatment for lung cancer and evaluate if treatment efficacy differed between single and multimodal interventions. Methods: Relevant literature published in MEDLINE, Scopus, Cochrane Library, CINAHL, and ProQuest from January 2003 to January 2023 was included. Included studies must have: participants over 16 years of age receiving treatment such as chemotherapy, radiotherapy, and/or surgery, cancer‐related fatigue (CRF) as an outcome, and must be randomized controlled trials. Two reviewers independently extracted data from eligible articles, and data analysis was performed using R 4.1.0 software. Results: Total of 14 randomized controlled trials were included and categorized into four groups: physical activities, traditional Chinese medicine (TCM), education, and dietary counselling. Our extensive search did not find any multimodal studies related to CRF in patients with lung cancer. Pooled results of this systematic review found that TCM and education interventions have a significant positive impact on fatigue in patients with lung cancer. Physical activity and dietary counselling were not effective in managing fatigue. None of the reported nonpharmacological interventions in this review significantly impact QoL. Conclusions: This review identified that TCM and educational programs improved CRF in patients with lung cancer. However, physical activities and dietary counselling did not show any improvements in fatigue for patients undergoing lung cancer treatment. Registration: PROSPERO registration ID: CRD42023407326.
- Open Access
- 19 October 2025
- Published by JMIR Publications Inc. in JMIR Preprints
A Personalized, Home-Based, Multidisciplinary Outpatient Clinic for Managing Breathlessness in Chronic Obstructive Pulmonary Disease: Protocol for a Single-Arm, Mixed-Methods Cohort Study (Preprint)
BACKGROUND Breathlessness is a distressing symptom for people with chronic obstructive pulmonary disease (COPD), impacting independence and community participation, resulting in reduced quality of life. With optimized treatment, nonpharmaceutical interventions deployed in a home-based breathlessness intervention service may reduce breathlessness to a manageable level. OBJECTIVE The aim of this study is to investigate whether patients with COPD experience reduced burden of chronic breathlessness and health care use following participation in the Macarthur Breathless Clinic (MBC), a multidisciplinary home-based health service intervention and to explore participant and carer experiences. METHODS The proposed research is a single-site, mixed methods, single-arm cohort study evaluating MBC. Eligible participants will have chronic breathlessness as defined by a modified Medical Research Council score of at least 2 and COPD confirmed by spirometry. Initially, participants will undergo a holistic medical assessment to understand factors contributing to breathlessness and to optimize therapy. The MBC intervention will be a 9-week, home-based, multidisciplinary program (with contributions from medical, nursing, physiotherapy, and occupational therapy clinicians). Central to this program will be coaching for breathlessness self-management using individualized, multicomponent strategies. Breathlessness impact will be assessed using questionnaire instruments measuring breathlessness mastery, symptom burden, quality of life, and psychological distress, with the Chronic Respiratory Questionnaire’s mastery subscale as primary outcome. Assessments will be undertaken at baseline, 9 weeks, and 52 weeks; 12-month exacerbation rates, health care use, and rescue medication use will be monitored and measured against participants’ historical data. Participant and carer experiences will be evaluated using qualitative methods to inform development of the service. RESULTS This project was funded in stages according to defined milestones, with the final milestone payment received in October 2025. Data collection commenced in March 2022. On submission of this manuscript, recruitment is complete with 92 participants having completed the protocol by March 2024. Data analysis is ongoing, and results are expected to be reported by early 2027. CONCLUSIONS This research protocol is the first to investigate long-term outcomes following a health service intervention targeting chronic breathlessness for patients with COPD. Positive results may see breathlessness strategies from MBC or other similar health service interventions incorporated into existing models of chronic COPD care. CLINICALTRIAL Australian and New Zealand Clinical Trial Registry ACTRN12620001330932; https://tinyurl.com/35fec8h4 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/85766
- 19 October 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessA Personalized, Home-Based, Multidisciplinary Outpatient Clinic for Managing Breathlessness in Chronic Obstructive Pulmonary Disease: Protocol for a Single-Arm, Mixed-Methods Cohort Study (Preprint)
BACKGROUND Breathlessness is a distressing symptom for people with chronic obstructive pulmonary disease (COPD), impacting independence and community participation, resulting in reduced quality of life. With optimized treatment, nonpharmaceutical interventions deployed in a home-based breathlessness intervention service may reduce breathlessness to a manageable level. OBJECTIVE The aim of this study is to investigate whether patients with COPD experience reduced burden of chronic breathlessness and health care use following participation in the Macarthur Breathless Clinic (MBC), a multidisciplinary home-based health service intervention and to explore participant and carer experiences. METHODS The proposed research is a single-site, mixed methods, single-arm cohort study evaluating MBC. Eligible participants will have chronic breathlessness as defined by a modified Medical Research Council score of at least 2 and COPD confirmed by spirometry. Initially, participants will undergo a holistic medical assessment to understand factors contributing to breathlessness and to optimize therapy. The MBC intervention will be a 9-week, home-based, multidisciplinary program (with contributions from medical, nursing, physiotherapy, and occupational therapy clinicians). Central to this program will be coaching for breathlessness self-management using individualized, multicomponent strategies. Breathlessness impact will be assessed using questionnaire instruments measuring breathlessness mastery, symptom burden, quality of life, and psychological distress, with the Chronic Respiratory Questionnaire’s mastery subscale as primary outcome. Assessments will be undertaken at baseline, 9 weeks, and 52 weeks; 12-month exacerbation rates, health care use, and rescue medication use will be monitored and measured against participants’ historical data. Participant and carer experiences will be evaluated using qualitative methods to inform development of the service. RESULTS This project was funded in stages according to defined milestones, with the final milestone payment received in October 2025. Data collection commenced in March 2022. On submission of this manuscript, recruitment is complete with 92 participants having completed the protocol by March 2024. Data analysis is ongoing, and results are expected to be reported by early 2027. CONCLUSIONS This research protocol is the first to investigate long-term outcomes following a health service intervention targeting chronic breathlessness for patients with COPD. Positive results may see breathlessness strategies from MBC or other similar health service interventions incorporated into existing models of chronic COPD care. CLINICALTRIAL Australian and New Zealand Clinical Trial Registry ACTRN12620001330932; https://tinyurl.com/35fec8h4 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/85766
- Open Access
- 16 April 2025
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 22 (4) , 621
Analysis of Assessment Methods for Detecting Nicotine Residue and Its Impact on Humans: A Systematic Review
Introduction: Thirdhand smoke (THS) was first identified by Graham and colleagues in 1953, and nicotine was detected in household dust from smokers in 1991. Thirdhand smoke (THS) consists of toxic nicotine residues that persist on surfaces long after tobacco use, posing a significant public health concern. Individuals can be exposed to thirdhand smoke through skin contact or inhalation, particularly affecting children and infants who are most vulnerable to tobacco contaminants. This review aims to assess the effectiveness of different methods for measuring nicotine THS residues to evaluate their accuracy across various age groups. Methods: Relevant literature was sourced from databases including ProQuest (Ovid), Medline (Ovid), Embase (Ovid), Scopus, and the Cochrane Library. The timeframe for included studies ranged the last 25 years, from 1999 to 2024. Eligible participants consisted of human populations exposed to thirdhand smoke residue. For this review, the animal studies were excluded. There were no restrictions regarding age, sex, ethnicity, or nationality for participant selection. For data management and screening, the Covidence systematic tool was utilized. Data extraction was performed independently by two reviewers. This protocol was registered with PROSPERO (CRD42024574140). Results: A total of 394 studies were retrieved from 5 databases for the initial screening. A total of 67 studies included in full-text screening, and ultimately, 36 studies were selected for full review. The studies were classified into four categories based on assessment methods: (1) analysis of human secretions, including salivary or urinary tests; (2) cellular analysis utilizing cellulose substrates or paper-based materials; (3) environmental assessments, which examined outdoor surfaces, vehicles, residential spaces, and fabrics; and (4) epidemiological assessments, employing surveys or questionnaires. Non-invasive matrices such as saliva and urine were frequently utilized for biomarker analysis. The studies collectively investigated nicotine and its metabolites in human biological samples, environmental surface contamination, and thirdhand smoke (THS) exposure. They employed a diverse range of assessment tools including surveys, machine learning technique, and cellulose-based substrates. Conclusions: This review identified various selective testing methods for detecting thirdhand smoke (THS) from nicotine. These assessment methods have advantages and disadvantages and underscores the need for further research. Improving these techniques for assessment of THS could significantly improve our understanding of the impact THS has on human health.
- 16 April 2025
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 22 (4) , 621
Open AccessAnalysis of Assessment Methods for Detecting Nicotine Residue and Its Impact on Humans: A Systematic Review
Introduction: Thirdhand smoke (THS) was first identified by Graham and colleagues in 1953, and nicotine was detected in household dust from smokers in 1991. Thirdhand smoke (THS) consists of toxic nicotine residues that persist on surfaces long after tobacco use, posing a significant public health concern. Individuals can be exposed to thirdhand smoke through skin contact or inhalation, particularly affecting children and infants who are most vulnerable to tobacco contaminants. This review aims to assess the effectiveness of different methods for measuring nicotine THS residues to evaluate their accuracy across various age groups. Methods: Relevant literature was sourced from databases including ProQuest (Ovid), Medline (Ovid), Embase (Ovid), Scopus, and the Cochrane Library. The timeframe for included studies ranged the last 25 years, from 1999 to 2024. Eligible participants consisted of human populations exposed to thirdhand smoke residue. For this review, the animal studies were excluded. There were no restrictions regarding age, sex, ethnicity, or nationality for participant selection. For data management and screening, the Covidence systematic tool was utilized. Data extraction was performed independently by two reviewers. This protocol was registered with PROSPERO (CRD42024574140). Results: A total of 394 studies were retrieved from 5 databases for the initial screening. A total of 67 studies included in full-text screening, and ultimately, 36 studies were selected for full review. The studies were classified into four categories based on assessment methods: (1) analysis of human secretions, including salivary or urinary tests; (2) cellular analysis utilizing cellulose substrates or paper-based materials; (3) environmental assessments, which examined outdoor surfaces, vehicles, residential spaces, and fabrics; and (4) epidemiological assessments, employing surveys or questionnaires. Non-invasive matrices such as saliva and urine were frequently utilized for biomarker analysis. The studies collectively investigated nicotine and its metabolites in human biological samples, environmental surface contamination, and thirdhand smoke (THS) exposure. They employed a diverse range of assessment tools including surveys, machine learning technique, and cellulose-based substrates. Conclusions: This review identified various selective testing methods for detecting thirdhand smoke (THS) from nicotine. These assessment methods have advantages and disadvantages and underscores the need for further research. Improving these techniques for assessment of THS could significantly improve our understanding of the impact THS has on human health.
- Open Access
- 21 March 2025
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 22 (4) , 465
The Effects of Thirdhand Vape Residue from Nicotine and Non-Nicotine Vapes on Cells: A Systematic Review
Rationale: Vapes are increasingly popular, however, their clouds leave a residue on surfaces, referred to as thirdhand smoke. Recent studies have reported the detrimental cellular impacts of thirdhand smoke. However, research on thirdhand vape residue exposure is relatively new and understudied. Objectives: This review aims to evaluate the current literature associated with the impact of thirdhand vape residue from nicotine and non-nicotine vapes on cells, compared to unexposed controls. Methods: A systematic search was performed in PubMed (Medline), Embase, Web of Science, Scopus, and Google databases to identify relevant studies. Two independent reviewers screened articles using the inclusion criteria of controlled experimental studies on human and animal in vitro and in vivo models which investigate thirdhand vape residue as the exposure variable and cell concepts. Studies were assessed for bias through tools specialised for animal studies. Data were extracted and synthesised in accordance with PRISMA guidelines. Results: Of 139 articles retrieved, three are included in this review, focusing on mice cell models only, one of which investigates non-nicotine vapes. No studies on human cell models that fit the criteria were found. Mice were directly exposed to vape-infused materials from which their cells were extracted and evaluated, finding that exposure to thirdhand nicotine vape residue damages mice cells. The effects of non-nicotine vapes are inconclusive. Conclusions: Thirdhand nicotine vape residue contributes to changes in some cells in mouse models but not others. Data available to date provide no convincing evidence of likely significant harm to humans. Further investigation is warranted to confirm or deny this impression.
- 21 March 2025
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 22 (4) , 465
Open AccessThe Effects of Thirdhand Vape Residue from Nicotine and Non-Nicotine Vapes on Cells: A Systematic Review
Rationale: Vapes are increasingly popular, however, their clouds leave a residue on surfaces, referred to as thirdhand smoke. Recent studies have reported the detrimental cellular impacts of thirdhand smoke. However, research on thirdhand vape residue exposure is relatively new and understudied. Objectives: This review aims to evaluate the current literature associated with the impact of thirdhand vape residue from nicotine and non-nicotine vapes on cells, compared to unexposed controls. Methods: A systematic search was performed in PubMed (Medline), Embase, Web of Science, Scopus, and Google databases to identify relevant studies. Two independent reviewers screened articles using the inclusion criteria of controlled experimental studies on human and animal in vitro and in vivo models which investigate thirdhand vape residue as the exposure variable and cell concepts. Studies were assessed for bias through tools specialised for animal studies. Data were extracted and synthesised in accordance with PRISMA guidelines. Results: Of 139 articles retrieved, three are included in this review, focusing on mice cell models only, one of which investigates non-nicotine vapes. No studies on human cell models that fit the criteria were found. Mice were directly exposed to vape-infused materials from which their cells were extracted and evaluated, finding that exposure to thirdhand nicotine vape residue damages mice cells. The effects of non-nicotine vapes are inconclusive. Conclusions: Thirdhand nicotine vape residue contributes to changes in some cells in mouse models but not others. Data available to date provide no convincing evidence of likely significant harm to humans. Further investigation is warranted to confirm or deny this impression.
- Open Access
- 25 November 2024
- Published by Elsevier in Respiratory Medicine
- Vol. 236, 107885
Characteristics of rehabilitation programs for chronic respiratory diseases in Asia: A scoping review
- 25 November 2024
- Published by Elsevier in Respiratory Medicine
- Vol. 236, 107885
Open AccessCharacteristics of rehabilitation programs for chronic respiratory diseases in Asia: A scoping review
- 14 November 2024
- Published by Wiley in Respirology
- Vol. 30 (1) , 86-87
Leading women in respiratory clinical sciences: Letter from Australia
Special Series: Leading Women in Respiratory Clinical Sciences Series Editors: Anne-Marie Russel and Kathleen O Lindell See related Editorial.
- 14 November 2024
- Published by Wiley in Respirology
- Vol. 30 (1) , 86-87
Leading women in respiratory clinical sciences: Letter from Australia
Special Series: Leading Women in Respiratory Clinical Sciences Series Editors: Anne-Marie Russel and Kathleen O Lindell See related Editorial.
- 20 July 2024
- Published by SAGE Publications in Journal of Infection Prevention
- Vol. 26 (2) , 67-77
A review of mask fit testing data associated with protocols utilized in evaluating the efficacy of N95 masks for health care workers
Background: Quantitative mask fit testing (QNFT) is the gold standard to confirm the correct fit of a N95/P2 mask to ensure health care workers protection from airborne viruses. Using the Occupational Safety and Health Administration (OSHA) guidance indicates a final fit test result is a cumulative score derived from manoeuvres within the OSHA protocol. The protocol-based manoeuvres mimic aspects of clinical care by health professionals and mask fit testing is conducted to provide protection from airborne viruses and pollutants within a care setting. Objective(s): To determine whether studies undertaking QNFT report the results of individual manoeuvres of the OSHA protocol. Methods: A comprehensive search strategy for the systematic review was developed to determine eligible studies, published between May 2011 and May 2021. Two researchers independently screened all full text articles retrieved and all disagreements were resolved through discussion. Results: The search found 557 studies. After removing 119 duplicates, 437 articles were reviewed based on title and abstract, 411 studies were excluded. Twenty-seven full text articles were assessed for eligibility, all were excluded for the following reasons: study did not report the results of the long or short OSHA protocol (12), study did not assess mask fit using the long or short OSHA protocol (10), article type (discussion/commentary/editorial) or wrong study type (1). Despite the use of very broad search terms no eligible studies were found and the result was declared an empty review. Conclusion: Internationally accepted QNFT protocols have a number of manoeuvres that reflect health care workers’ physical movements during the delivery of clinical care. Studies of mask fit testing appear to lack the reporting of outcomes for each manoeuvre with only the cumulative results being provided. This finding raises the need to understand potential risk from a mask leak during the delivery of clinical care as evidenced by failing a manoeuvre during mask fit testing. Further research is required to understand the importance of passing each mask fit testing manoeuvre and the relationship to airborne protection during the delivery of clinical care.
- 20 July 2024
- Published by SAGE Publications in Journal of Infection Prevention
- Vol. 26 (2) , 67-77
A review of mask fit testing data associated with protocols utilized in evaluating the efficacy of N95 masks for health care workers
Background: Quantitative mask fit testing (QNFT) is the gold standard to confirm the correct fit of a N95/P2 mask to ensure health care workers protection from airborne viruses. Using the Occupational Safety and Health Administration (OSHA) guidance indicates a final fit test result is a cumulative score derived from manoeuvres within the OSHA protocol. The protocol-based manoeuvres mimic aspects of clinical care by health professionals and mask fit testing is conducted to provide protection from airborne viruses and pollutants within a care setting. Objective(s): To determine whether studies undertaking QNFT report the results of individual manoeuvres of the OSHA protocol. Methods: A comprehensive search strategy for the systematic review was developed to determine eligible studies, published between May 2011 and May 2021. Two researchers independently screened all full text articles retrieved and all disagreements were resolved through discussion. Results: The search found 557 studies. After removing 119 duplicates, 437 articles were reviewed based on title and abstract, 411 studies were excluded. Twenty-seven full text articles were assessed for eligibility, all were excluded for the following reasons: study did not report the results of the long or short OSHA protocol (12), study did not assess mask fit using the long or short OSHA protocol (10), article type (discussion/commentary/editorial) or wrong study type (1). Despite the use of very broad search terms no eligible studies were found and the result was declared an empty review. Conclusion: Internationally accepted QNFT protocols have a number of manoeuvres that reflect health care workers’ physical movements during the delivery of clinical care. Studies of mask fit testing appear to lack the reporting of outcomes for each manoeuvre with only the cumulative results being provided. This finding raises the need to understand potential risk from a mask leak during the delivery of clinical care as evidenced by failing a manoeuvre during mask fit testing. Further research is required to understand the importance of passing each mask fit testing manoeuvre and the relationship to airborne protection during the delivery of clinical care.